Vincerx Pharma, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vincerx Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q2 2024.
  • Vincerx Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $912K, a 16.6% decline year-over-year.
  • Vincerx Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.53M, a 35.4% decline year-over-year.
  • Vincerx Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.56M, a 64.6% decline from 2022.
  • Vincerx Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.1M, a 56.9% decline from 2021.
  • Vincerx Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $23.3M, a 432% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.53M $912K -$181K -16.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.71M $528K -$856K -61.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $3.56M -$251K +$603K +70.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $2.96M $1.34M -$953K -41.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.91M $1.09M -$2.27M -67.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $6.18M $1.38M -$3.87M -73.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $10.1M -$854K -$6.74M -115% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $16.8M $2.29M -$3.79M -62.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $20.6M $3.36M -$3.28M -49.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $23.9M $5.26M +$543K +11.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $23.3M $5.89M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 $6.08M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $6.64M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $4.72M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.